Tics and Tourette syndrome

Psychiatric Clinics of North America

Volumn 37, Issue 3, 2014, Pages 269-286

  Shaw, Zoey A ^a   Coffey, Barbara J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbidity; Obsessive compulsive disorder; Tic disorder; Tics; Tourette syndrome; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ARIPIPRAZOLE; ATOMOXETINE; BACLOFEN; BOTULINUM TOXIN A; CLONAZEPAM; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; FLUVOXAMINE; GUANFACINE; HALOPERIDOL; METHYLPHENIDATE; NICOTINE GUM; OLANZAPINE; PIMOZIDE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRABENAZINE; TOPIRAMATE; ZIPRASIDONE; PSYCHOTROPIC AGENT;

AKATHISIA; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DROWSINESS; DYSTONIA; EXPOSURE AND RESPONSE PREVENTION; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC ASSOCIATION; GILLES DE LA TOURETTE SYNDROME; GLUCOSE INTOLERANCE; HABIT REVERSAL THERAPY; HEADACHE; HUMAN; HYPOTENSION; LIVER TOXICITY; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TARDIVE DYSKINESIA; TARDIVE DYSTONIA; TIC; UNSPECIFIED SIDE EFFECT; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; GENETICS; MOOD DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; TIC DISORDERS; TOURETTE SYNDROME;

ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; COMORBIDITY; HUMANS; MOOD DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTROPIC DRUGS; TIC DISORDERS; TOURETTE SYNDROME;

EID: 84906281632     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2014.05.001     Document Type: Review

References (92)

1. Robertson M.M., Eapen V., Cavanna A.E. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. JPsychosom Res 2009, 67(6):475-483.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Association, Arlington (VA). 5th edition.
3. Robertson M.M. The Gilles de la Tourette syndrome: the current status. Arch Dis Child Educ Pract Ed 2012, 97(5):166-175.
4. Bloch M.H., Leckman J.F. Clinical course of Tourette syndrome. JPsychosom Res 2009, 67:497-501.
5. Bloch M.H., Peterson B.S., Scahill L., et al. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med 2006, 160(1):65-69.
6. Reese H.E., Scahill L., Peterson A.L., et al. The premonitory urge to tic: measurement, characteristics, and correlates in older adolescents and adults. Behav Ther 2014, 45:177-186.
7. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123:425-462.
8. Coffey B., Miguel E., Biederman J., et al. Tourette's disorder with and without obsessive compulsive disorder in adults: are they different?. JNerv Ment Dis 1998, 186:201-215.
9. Centers for Disease Control and Prevention Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years-United States, 2007. MMWR Morb Mortal Wkly Rep 2009, 58(21):581-585.
10. Linazasoro G., Van Blercom N., de Zarate C.O. Prevalence of tic disorder in two schools in the Basque country: results and methodological caveats. Mov Disord 2006, 21(12):106-109.
11. Khalifa N., Von Knorring A.L. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol 2003, 45:315-319.
12. Freeman R.D., Tourette Syndrome International Database Consortium Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry 2007, 16(1):15-23.
13. Spencer T., Biederman T., Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 1999, 46(5):915-927.
14. Grad L.R., Pelcovits D., Olson M., et al. Obsessive-compulsive symptomatology in children with Tourette's syndrome. JAm Acad Child Adolesc Psychiatry 1987, 26:69-73.
15. Swedo S., Rapoport J., Leonard H., et al. Obsessive compulsive disorder in children and adolescents. Arch Gen Psychiatry 1989, 46:335.
16. Robertson M., Banerjee S., Fox Hiley P., et al. Personality disorders and psychopathology in Tourette's syndrome: a controlled study. Br J Psychiatry 1997, 171:283-286.
17. Hyde T.M., Aaronson B.A., Randolph C., et al. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Br J Psychiatry 1994, 164:811-817.
18. Price R.A., Kidd K.K., Cohen D.J., et al. Atwin study of Tourette syndrome. Arch Gen Psychiatry 1985, 42:815-820.
19. Scharf J.M., Yu C.A., Matthews B.M., et al. Genome-wide association study of Tourette syndrome. Mol Psychiatry 2013, 18(6):721-728.
20. Kurlan R., Eapen V., Stern J., et al. Bilineal transmission in Tourette's syndrome families. Neurology 1994, 44(12):2336-2342.
21. Swain J.E., Scahill L., Lombroso P.J., et al. Tourette syndrome and tic disorders: a decade of progress. JAm Acad Child Adolesc Psychiatry 2007, 46:947-968.
22. Abelson J.F., Kwan K.Y., O'Roak B.J., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
23. Fabbrini G., Pasquini M., Aurilia C., et al. Large Italian family with Gilles de la Tourette syndrome: clinical study and analysis of the SLITRK1 gene. Mov Disord 2007, 22:2229-2234.
24. Scharf J.M., Moorjani P., Fagerness J., et al. Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample. Neurology 2008, 70:1495-1496.
25. Ercan-Sencicek A.G., Stillman A.A., Ghosh A.K., et al. L-histidine decarboxylase and Tourette's syndrome. NEngl J Med 2010, 362:1901-1908.
26. Wolf S.S., Jones D.W., Knable M.B., et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996, 273:1225-1227.
27. Singer H.S., Minzer K. Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev 2003, 25(1):70-84.
28. Rauch S.L. Neuroimaging research and the neurobiology of obsessive compulsive disorder: where do we go from here?. Biol Psychiatry 2000, 47:168-170.
29. Whiteside S.P., Port J.D., Abramowitz J.S. Ameta-analysis of functional neuroimaging on obsessive-compulsive disorder. Psychiatry Res 2004, 132:69-79.
30. Bloch M.H., Leckman J.F., Zhu H., et al. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005, 65(8):1253-1258.
31. Leckman J.F., Zhang H., Vitale A., et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998, 102(1):14-19.
32. Kwak C., Dat Voung K., Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 2003, 18(12):1530-1533.
33. Cohen A.J., Leckman J.F. Sensory phenomena associated with Gilles de la Tourette's syndrome. JClin Psychiatry 1992, 53(9):319-323.
34. Jackson S.R., Parkinson A., Kim S.Y., et al. On the functional anatomy of the urge-for-action. Cogn Neurosci 2011, 2(3-4):227-243.
35. Conelea C.A., Woods D.W. The influence of contextual factors on tic expression in Tourette's syndrome: a review. JPsychosom Res 2008, 65:487-496.
36. Himle M.B., Woods D.W., Conelea C.A., et al. Investigating the effects of tic suppression on premonitory urge ratings in children and adolescents with Tourette's syndrome. Behav Res Ther 2007, 45(12):2964-2976.
37. Coffey B.J., Jummani R. ADHD and Tourette's disorder. Attention-deficit hyperactivity disorder in adults and children 2014, Cambridge University Press, New York. L. Adler (Ed.).
38. Storch E.A., Lack C.W., Simons L.E., et al. Ameasure of functional impairment in youth with Tourette's syndrome. JPediatr Psychol 2007, 32:950-959.
39. Kurlan R., Como P.G., Miller B., et al. The behavioral spectrum of tic disorders: a community-based study. Neurology 2002, 59(3):414-420.
40. Coffey B., Biederman J., Geller D., et al. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. JAm Acad Child Adolesc Psychiatry 2000, 39:556-561.
41. Pauls D.L. The genetics of obsessive compulsive disorder and Gilles de la Tourette's syndrome. Psychiatr Clin North Am 1992, 15:759-766.
42. Miguel E.C., Coffey B.J., Baer L., et al. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. JClin Psychiatry 1995, 56(6):246-255.
43. Miguel E.C., Baer L., Coffey B.J., et al. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry 1997, 170:140-145.
44. Leckman J.F., Walker D.E., Goodman W.K., et al. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry 1994, 151:675-680.
45. Swerdlow R.N., Zinner S., Farber H.R., et al. Symptoms in obsessive-compulsive disorder and Tourette syndrome: a spectrum?. CNS Spectr 1999, 4(3):21-33.
46. Cavanna A.E., Rickards H. The psychopathological spectrum of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1008-1015.
47. Carter A.S., O'Donnell D.A., Schultz R.T., et al. Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. JChild Psychol Psychiatry 2000, 41(2):215-223.
48. Burd L., Freeman R.D., Klug M.G., et al. Tourette syndrome and learning disabilities. BMC Pediatr 2005, 5:34.
49. Coffey B.J., Zwilling A. Psychiatric conditions associated with Tourette syndrome. Afamily's guide to Tourette syndrome 2012, 24-27. Tourette's Syndrome Association, Bayside (NY). J.T. Walkup (Ed.).
50. Kerbeshian J., Burd L., Klug M. Comorbid Tourette's disorder and bipolar disorder: an etiologic perspective. Am J Psychiatry 1995, 152:1646-1651.
51. Pauls D.L., Leckman J.F., Cohen D.J. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. JAm Acad Child Adolesc Psychiatry 1993, 32:1044-1050.
52. Haddad A.D., Umoh G., Bhatia V., et al. Adults with Tourette's syndrome with and without attention deficit hyperactivity disorder. Acta Psychiatr Scand 2009, 1240(4):299-307.
53. Spencer T., Biederman J., Coffey B., et al. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999, 56:842-847.
54. Robertson M.M., Channon S., Baker J., et al. The psychopathology of Gilles de la Tourette's syndrome. A controlled study. Br J Psychiatry 1993, 162:114-117.
55. Coffey B., Biederman J., Smoller J., et al. Anxiety disorders and Tic severity in juveniles with Tourette's disorder. JAm Acad Child Adolesc Psychiatry 2000, 39:562-568.
56. Comings B.G., Comings D.E. Acontrolled study of Tourette syndrome V. Depression and mania. Am J Hum Genet 1987, 41:804-821.
57. Gorman D.A., Thompson N., Plessen K.J., et al. Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study. Br J Psychiatry 2010, 99:39-60.
58. Leckman J.F., Riddle M.A., Hardin M.T., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. JAm Acad Child Adolesc Psychiatry 1989, 28(4):566-573.
59. Hartmann A., Worbe Y. Pharmacological treatment of Gilles de la Tourette syndrome. Neurosci Biobehav Rev 2013, 37:1157-1161.
60. Verdellen C., van de Griendt J., Hartmann A., ESSTS Guidelines Group, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011, 20:197-207.
61. Frank M., Cavanna A.E. Behavioral treatments for Tourette syndrome: an evidence-based review. Behav Neurol 2013, 27(1):105-117.
62. McGuire J.F., Piacentini J., Brennan E.A., et al. Ameta-analysis of behavior therapy for Tourette syndrome. JPsychiatr Res 2014, 50:106-112.
63. Piacentini J., Woods D.W., Scahill L., et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010, 303(19):1929-1937.
64. Verdellen C.W., Keijsers G.P., Cath D.C., et al. Exposure with response prevention versus habit reversal in Tourette's syndrome: a controlled study. Behav Res Ther 2004, 42:501-511.
65. Scahill L., Chappell P.B., Kim Y.S., et al. Aplacebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067-1074.
66. Leckman J.F., Hardin M.T., Riddle M.A., et al. Clonidine treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1991, 48:324-328.
67. Chen J.J., Ondo W.G., Dashtipour K., et al. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 2012, 34:1487-1504.
68. Panagiotopoulos C., Ronsley R., Elbe D., et al. First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents. JCan Acad Child Adolesc Psychiatry 2010, 19:124-137.
69. Correll C.U., Kane J.M. One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review. JChild Adolesc Psychopharmacol 2007, 17:647-656.
70. Gilbert D.L., Batterson J.R., Sethuraman G., et al. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. JAm Acad Child Adolesc Psychiatry 2004, 43(2):206-214.
71. Dion Y., Annable L., Sandor P., et al. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. JClin Psychopharmacol 2002, 22(1):31-39.
72. Onofrj M., Paci C., D'Andreamatteo G., et al. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. JNeurol 2000, 247:443-446.
73. Sallee F.R., Kurlan R., Goetz C.G., et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. JAm Acad Child Adolesc Psychiatry 2000, 39:292-299.
74. Otsuka Pharmaceutical Development & Commercialization Safety and tolerability of once-daily oral aripiprazole in children and adolescents with Tourette's disorder 2000, National Library of Medicine (US), Bethesda (MD), Available at:, Accessed April 22, 2014. http://clinicaltrials.gov/show/NCT01727713.
75. Cui Y.H., Zheng Y., Yang Y.P., et al. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China. JChild Adolesc Psychopharmacol 2010, 20(4):291-298.
76. Lyon G.J., Samar S., Jummani R., et al. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study. JChild Adolesc Psychopharmacol 2009, 19(6):623-633.
77. Murphy T.K., Bengtson M.A., Soto O., et al. Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopharmacol 2005, 83(3):489-490.
78. Jankovic J. Botulinum toxin in movement disorders. Curr Opin Neurol 1994, 7:358-366.
79. Kwak C.H., Hanna P.A., Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57:1190-1193.
80. Allen A.J., Kurlan R.M., Gilbert D.L., et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005, 65:1941-1949.
81. Porta M., Sassi M., Cavallazzi M., et al. Tourette's syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig 2008, 28(7):443-459.
82. Jankovic J., Jimenez-Shahed J., Brown L.W. Arandomized, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. JNeurol Neurosurg Psychiatry 2010, 81(1):70-73.
83. Yang C.S., Zhang L.L., Zeng L.N., et al. Topiramate for Tourette's syndrome in children: a meta-analysis. Pediatr Neurol 2013, 49(5):344-350.
84. Awaad Y. Tics in Tourette syndrome: new treatment options. JChild Neurol 1999, 14(5):316-319.
85. Silver A.A., Shytle R.D., Philipp M.K., et al. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. JClin Psychiatry 2001, 62(9):707-714.
86. McDougle C.J., Goodman W.K., Leckman J.F., et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo controlled study in patients with and without tics. Arch Gen Psychiatry 1994, 51(4):302-308.
87. Geller D.A., Biederman J., Stewart S.E., et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003, 160(11):1919-1928.
88. March J.S., Franklin M.E., Leonard H., et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007, 61(3):344-347.
89. Lowe T.L., Cohen D.J., Detlor J., et al. Stimulant medications precipitate Tourette's syndrome. JAMA 1982, 247(12):1729-1731.
90. Gadow K.D., Sverd J., Sprafkin J., et al. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 1995, 52(6):444-455.
91. Tourette's Syndrome Study Group Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58(4):527-536.
92. Bloch M.H., Panza K.E., Landeros-Weisenberger A., et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. JAm Acad Child Adolesc Psychiatry 2009, 48(9):884-893.